Close

Citi Maintains a 'Neutral' on Regeneron Pharma (REGN); Doctors Consider Eylea as Replacement for Roche's Lucentis

Go back to Citi Maintains a 'Neutral' on Regeneron Pharma (REGN); Doctors Consider Eylea as Replacement for Roche's Lucentis
Regeneron (NASDAQ: REGN) Delayed: 959.92 -4.55 (0.47%)
Previous Close $964.47    52 Week High $592.36 
Open $970.00    52 Week Low $325.35 
Day High $970.71    P/E 251.95 
Day Low $959.49    EPS $3.81 
Volume 360,153       

Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) Delayed: 32.18 -0.46 (1.41%)
Previous Close $32.64    52 Week High $35.13 
Open $32.39    52 Week Low $28.10 
Day High $32.45    P/E N/A 
Day Low $32.15    EPS $0.00 
Volume 1,427,900